Profound Medical Corp. ( PROF) - Stock Earnings
PROF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
PROF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.0 million USD | 5.3 million USD |
| 2025Q4 | -8.3 million USD | 6.1 million USD |
| 2026Q1 | -7.0 million USD | 5.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PROF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.6 million USD | 7.2 million USD |
| 2024 | -26.5 million USD | 10.2 million USD |
| 2025 | -43.3 million USD | 16.4 million USD |
| 2026 Est. | — | — |
PROF
Price: $7.26
52 week price:
Earnings Per Share: -1.24 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: Canada
Volume: 115158
Market Capitalization: 223.0 million